United-Guardian Inc
🔔 Watch stock
Stock Watch
Stock Watch will tell you what changes at United-Guardian Inc.
Later $1 a month per stock — signing up is free, and you'll be the first to know when it launches.
Price history
Chart
Interactive price chart (TradingView).
52-week range: 5.60 $ to 8.20 $ · Last price: 7.20 $ (As of: September 17, 2026)
Key figures
Key figures at a glance
Every figure we hold for this stock, grouped by topic. The question mark next to a label explains what the number means.
Basics
Performance
Technical Indicators
Calculated from the price history · as of 09/18/2026
Valuation
Profitability
Balance Sheet & Safety
Growth
Dividend
Quality & Screener
Highlighted are things our editorial team noticed: green = stands out as strong, red = deserves a closer look. No single metric is a verdict on its own — always read it in context.
Comparison
Industry comparison
The stock alongside the largest companies in the same group. The median row is the middle value of the companies shown above — not of the whole industry.
Industry: Household & Personal Products
| Company | Market cap ($B) | P/E | EV/EBITDA | Gross Margin % | EBIT Margin % | Sales Growth (Year) % | Perf. 1Y % |
|---|---|---|---|---|---|---|---|
| United-Guardian Inc UG | 0.0 | 14.4 | 9.5 | 46.9 | – | -13.4 | -2.7 |
| Procter & Gamble Company PG | 346.0 | 22.1 | 14.9 | 50.9 | 23.1 | 0.3 | -5.3 |
| Colgate-Palmolive Company CL | 70.6 | 35.0 | 19.7 | 60.4 | 20.9 | 1.4 | 9.4 |
| Estee Lauder Companies Inc EL | 34.0 | – | 25.1 | 75.5 | 14.9 | -8.5 | 8.0 |
| Kenvue Inc. KVUE | 33.3 | 21.5 | 13.0 | 58.4 | 21.6 | -2.1 | 3.1 |
| Kimberly-Clark Corporation KMB | 32.6 | 19.3 | 12.0 | 37.6 | 19.7 | -14.2 | -17.5 |
| Church & Dwight Company Inc CHD | 22.5 | 31.9 | 18.7 | 45.6 | 20.2 | 1.6 | 4.7 |
| The Clorox Company CLX | 10.3 | 14.2 | 13.9 | 42.3 | 17.0 | 0.2 | -29.1 |
| ELF Beauty Inc ELF | 5.5 | 213.6 | 28.0 | 71.6 | 1.7 | 24.6 | -36.1 |
| Median of companies shown | 32.6 | 21.8 | 14.9 | 50.9 | 19.9 | 0.2 | -2.7 |
Based on the most recently reported figures. Only stocks from the same trading venue are lined up, so the market caps are counted in one currency. Compare in a chart →
Fiscal years
Annual Figures
Fiscal years from the audited annual reports, oldest first. EBIT is the operating profit before interest and taxes; total assets are everything the company owns.
Revenue, operating income and net income per fiscal year $M
Revenue Operating income Net income
| Fiscal Year | Revenue ($M) | EBIT ($M) | Net Income ($M) | EPS ($) | Operating Cash Flow ($M) | Equity ($M) | Total Assets ($M) |
|---|---|---|---|---|---|---|---|
| 2016 | 11 | 3 | 3 | 0.56 | 2 | 14 | 15 |
| 2017 | 13 | 5 | 4 | 0.84 | 4 | 11 | 13 |
| 2018 | 14 | 6 | 4 | 0.95 | 5 | 11 | 13 |
| 2019 | 14 | 5 | 5 | 1.04 | 4 | 11 | 12 |
| 2020 | 11 | 4 | 3 | 0.72 | 4 | 10 | 12 |
| 2021 | 14 | 6 | 5 | 1.01 | 5 | 10 | 12 |
| 2022 | 13 | 4 | 3 | 0.56 | 3 | 9 | 11 |
| 2023 | 11 | 3 | 3 | 0.56 | 3 | 11 | 13 |
| 2024 | 12 | 4 | 3 | 0.71 | 3 | 12 | 14 |
| 2025 | 11 | 2 | 2 | 0.46 | 2 | 11 | 13 |
Quarters
Quarterly Figures
Each bar is one quarter, the last one is the most recent. Use the switch to step through the individual figures.
Revenue & Profit
Cash Flow
Balance Sheet
Margins
Per Share
Click the chart or tab into it, then use ← and → to step through the periods.
None of the selected stocks reports this metric. Pick another metric or switch between annual and quarterly.
· Total · per year
These companies report in different currencies — switch on “Indexed” or pick a margin for a fair comparison.
The figures could not be loaded right now.
Source: fundamental data
| Quarter | EPS (Earnings Per Share) | EPS YoY (%) | Sales ($M) | Sales YoY (%) | Net Margin (%) | OCF ($M) | FCF ($M) |
|---|---|---|---|---|---|---|---|
| 2024: Q4 | 0.11 | -31.60 | 3 | -5.00 | 20.30 | 0 | 0 |
| 2025: Q1 | 0.12 | -39.40 | 3 | -23.80 | 22.60 | 0 | 0 |
| 2025: Q2 | 0.14 | -34.40 | 3 | -16.30 | 22.10 | 0 | 0 |
| 2025: Q3 | 0.06 | -69.00 | 2 | -26.00 | 11.80 | 1 | 1 |
| 2025: Q4 | 0.14 | 29.00 | 3 | 19.60 | 21.90 | 0 | 0 |
| 2026: Q1 | 0.18 | 46.00 | 3 | 15.80 | 28.50 | 1 | 1 |
| 2026: Q2 | 0.16 | 14.30 | 3 | 10.70 | 22.60 | 2 | 2 |
What Do These Terms Mean?
- EPS (Earnings Per Share):
- Quarterly profit divided by the total share count — how much of the profit works out to a single share.
- YoY (Year over Year):
- Change versus the same quarter a year ago — this is how you compare without seasonal distortion (e.g. the holiday shopping season).
- Sales:
- All revenue for the quarter, before any costs are deducted — the top line of the income statement.
- Net Margin:
- What percentage of sales is left over as profit in the end. Negative means the company is posting a loss.
- OCF (Operating Cash Flow):
- The cash that actually flows into the till from the core business during the quarter — harder to dress up than book profit.
- FCF (Free Cash Flow):
- Operating cash flow minus capital expenditures — the money that's genuinely free to use, say for paying down debt, buybacks, or dividends.
Screening
Appears in These Scanners
This stock currently matches 6 of our scanner strategies — each hit links to the scanner.
Backtested Scanners
Growth
Breakout & Setup
Momentum & Trend
Only genuine hits from verified scanners count; pure ranking metrics (P/E, P/S, and similar, which just sort the whole universe) don't count as a hit. View all scanners
Valuation
What is priced in?
Instead of guessing what the stock is worth, we turn the question around: what free cash flow growth has to happen for today’s market value to add up? The assumptions behind it can be moved.
Today’s market value implies roughly -1.6% growth in free cash flow per year over ten years (assumptions: discount rate 10.0%, terminal growth 2.5%).
| Free cash flow (last twelve months) | $3.3M |
|---|---|
| Market cap | $34.0M |
| Free cash flow in year ten | $2.8M |
| Terminal value as a share of market value | 44.1% |
For comparison: over the past five years free cash flow shrank by 11.7% per year.
It shows which assumption is built into today’s price, not whether that assumption will hold. Every assumption can be changed with the sliders; the figures move with them.
A simplified model calculation — not a forecast and not a recommendation.
AI classification
AI Rating
Not yet rated — we only show a category once an SEC-backed file with at least two cited passages is available.
Growth
Growth Score
Ten checks against the annual reports — each one passed counts a point.
- Revenue grows by more than 15% a year over three years -6.0%
- More than 10% revenue growth is expected for the coming year -100.0%
- Share count grows by less than 3% a year 0.0%
- Revenue growth plus cash-flow margin add up to at least 40 ("Rule of 40") 4.7%
- Gross margin at 40% or higher and without meaningful erosion 47.7%
- Goodwill from acquisitions does not grow faster than revenue 0.0%
- Net debt below twice EBITDA 9 m net cash
- Operating cash flow covers the profits of the last three years 1 m
- Return on capital at 15% or higher, or up versus two years ago 19.6%
- Insiders hold at least 10% or are net buyers 35.9%
A criterion without figures counts neither as passed nor as failed; a score is only produced from 7 judgeable criteria upwards. Source: fundamental data. All ten criteria in detail
Quality check
AAQS
3/10The AAQS (AlleAktien Quality Score) checks 10 quality criteria on growth, profitability, and balance-sheet strength — per the methodology developed and published by AlleAktien, calculated by us from our own fundamental data. A stock counts as a quality stock from 9 out of 10 points. Where a company has a shorter listing history, we calculate over the fiscal years available (at least five).
- Sales growth 10Y > 5% -0.2%
- Exp. sales growth 3Y > 5% –
- EBIT growth 10Y > 5% -4.5%
- Exp. EBIT growth 3Y > 5% –
- Net debt < 4x EBIT –
- EBIT positive, 10Y straight 10
- Max. EBIT decline < 50% 60.5%
- Return on equity > 15% 18.8%
- ROCE > 15% 19.6%
- Expected return > 10% –
View stocks with the full AAQS score · Read the methodology at AlleAktien
Source: fundamental data
The company
About the Company
United-Guardian, Inc. entwickelt, fertigt, verkauft und vermarktet kosmetische Spezialinhaltsstoffe, pharmazeutische Produkte, medizinische Gleitmittel und Inhaltsstoffe für sexuelles Wohlbefinden in den USA und international.
- Employees
- 23
- Headquarters
- Hauppauge, NY
- Address
- 230 Marcus Boulevard, 11788 Hauppauge, United States
- Phone
- 631 273 0900
- Website
- u-g.com
- IPO Date
- 03/17/1992
- ISIN
- US9105711082
- Stock Split
- 6:5 on 09/12/1985
- Stock Split
- 11:10 on 02/26/1985
- Stock Split
- 21:20 on 04/17/1984
Management
| Name | Title | Birth Year |
|---|---|---|
| Donna Vigilante | President & Director | 1981 |
| Andrea J. Young | CFO, Treasurer, Controller, Secretary & Human Resources Manager | 1969 |
| Denise Costrini | Marketing Director | – |
Executives per the latest required filings; titles kept in their original language. Source: fundamental data.
Filings
Company Filings (8-K)
An 8-K is the filing a US company must use to disclose material events immediately — takeovers, changes at the top, major contracts or payment troubles, for instance. The links open the original document at the US Securities and Exchange Commission (SEC).
Data as of: September 17, 2026 · Source: fundamental data & SEC filings (annual and quarterly reports, 10-K/10-Q)
Note: pure fact-based analysis, not investment advice and not a solicitation to buy or sell. All figures without guarantee.